<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Strict glycemic control slows progression of retinopathy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Strict glycemic control slows progression of retinopathy</h1>
<div class="graphic"><div class="figure"><div class="ttl">Strict glycemic control slows progression of retinopathy</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Cumulative incidence of progressive retinopathy in patients with type 1 diabetes and very mild to moderate nonproliferative retinopathy who were treated with either conventional (dashed line) or intensive (solid line) insulin therapy for 9 years. There was an increasing benefit of intensive therapy over time, although intensive therapy was associated with transient worsening in the first year (p&lt;0.001).</div><div class="graphic_reference">Data from: Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977.</div><div id="graphicVersion">Graphic 61305 Version 8.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
